Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Bolus Versus Continuous Infusion Erector Spinae Catheters for Median Sternotomy Incisions
NCT05642416Phase 4Completed
- Sponsor
- Henry Ford Health
- Start
- Oct 2022
- Primary completion
- Dec 2024
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Henry Ford Health. Started Oct 2022; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05642416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05642416.